Pathogen: SARS-CoV-2

PANTHER

United Kingdom
|
2026
  • Adults (18-64 years)
  • General population
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Pharmacological intervention
  • Immunomodulator
  • Baricitinib
  • Statins
  • Simvastatin

EU-PROACT

France Norway Spain Belgium Italy United Kingdom Ireland Austria The Netherlands Switzerland
|
2025
  • Adults (18-64 years)
  • General population
  • Hospital
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus

ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
|
2024
  • Adults (18-64 years)
  • Community
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray

ECRAID-REMAP-CAP

Belgium Croatia Czech Republic Estonia France Germany Hungary Ireland Italy The Netherlands Portugal Serbia Slovenia Spain Switzerland United Kingdom
|
2018
  • Adults (18-64 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Pharmacological intervention
  • Immunomodulator
  • Corticosteroid
  • Baloxavir
  • Oseltamivir

ECRAID-EU-RECOVERY

France Italy The Netherlands Belgium Estonia Portugal Romania Spain Sweden
|
2020
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Pharmacological intervention
  • Antivirals
  • Corticosteroid
  • Baloxavir
  • Oseltamivir

Zurich Coronavirus Cohort

Switzerland
|
2020
  • Adults (18-64 years)
  • General population
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

EuCARE-HOSPITALISED

Sweden Italy Poland Portugal Germany Lithuania United Kingdom Kenya Brazil Mexico
|
2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Blood sample
  • Nasopharyngeal swab
  • Urine sample

EuCARE-POSTCOVID

Italy Poland Portugal Lithuania Brazil Mexico Germany
|
2022
  • Adults (18-64 years)
  • Hospital
  • Primary care
  • Emergency department
  • Non-hospital health centre
  • Long-term care facility
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Blood sample
  • Nasopharyngeal swab

MERMAIDS 2

Serbia Estonia Greece Montenegro Italy Romania Spain The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults (18-64 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood
  • Plasma

ADEQUATE

Serbia Belgium
|
2021-2025
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Syndromic diagnostic testing